Skip to main content
Terug
CME logo

CME Group Inc.

Datakwaliteit: 100%
CME
NASDAQ Financial Services Financial - Data & Stock Exchanges
€ 306,56
▼ € 0,76 (-0,25%)
Marktkapitalisatie: 110,21B
Dagbereik
€ 304,53 € 307,98
52-Weeksbereik
€ 248,53 € 329,16
Volume
1.787.374
50D / 200D Gem.
€ 299,02 / € 278,66
Vorige Slotkoers
€ 307,32

Koershistorie

Financiële Trends

Sectorvergelijking

vs Financial Services sector mediaan (854 peers)

Metriek Aandeel Sector Mediaan
P/E 27,3 10,3
P/B 3,8 1,1
ROE % 14,7 11,7
Net Margin % 62,0 16,8
Rev Growth 5Y % 8,6 11,7
D/E 0,1 0,5

Koersdoel Analisten

Hold
€ 311,83 +1.7%
Low: € 300,00 High: € 340,00
Forward K/W
25,5
Forward WPA
€ 12,04
WPA Groei (sch.)
+0,0%
Omzet Sch.
7 B

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2030 € 14,09
€ 13,43 – € 15,22
8,4 B 1
FY2029 € 15,04
€ 14,33 – € 16,24
8,3 B 1
FY2028 € 13,78
€ 12,82 – € 14,71
7,9 B 3

Insider Trading Activity

Buy ratio (90d) 0.0%
20 transactions
Date Insider Type Shares Price Value
Mar 15, 2026
Sprague Suzanne
COO & Global Head of Clearing
grant 5.504 € 311,40 € 1.713.946
Mar 15, 2026
Sprague Suzanne
COO & Global Head of Clearing
other 2.515 € 311,40 € 783.171
Mar 15, 2026
Vroman Ken
Chief Transformation Officer
grant 7.076 € 311,40 € 2.203.466
Mar 15, 2026
Vroman Ken
Chief Transformation Officer
other 3.135 € 311,40 € 976.239
Mar 12, 2026
Vroman Ken
Chief Transformation Officer
sell 5.160 € 309,00 € 1.594.440
Feb 23, 2026
Durkin Bryan T
Director
sell 4.200 € 309,65 € 1.300.530
Dec 11, 2025
DUFFY TERRENCE A
Chairman and CEO
sell 25.000 € 269,10 € 6.738.815
Aug 26, 2025
Cutinho Sunil
Chief Information Officer
sell 11.896 € 272,10 € 3.229.444
Jun 25, 2025
Carey Charles P
Director
grant 879 € 273,03 € 239.993
Jun 25, 2025
Tierney Robert J JR
Director
grant 532 € 273,03 € 145.252
Jun 25, 2025
Mulchrone Patrick J
Director
grant 532 € 273,03 € 145.252
Jun 25, 2025
Suskind Dennis
Director
grant 532 € 273,03 € 145.252
Jun 25, 2025
Durkin Bryan T
Director
grant 532 € 273,03 € 145.252
Jun 25, 2025
SIEGEL HOWARD J
Director
grant 879 € 273,03 € 239.993
Jun 25, 2025
Bitsberger Timothy S.
Director
grant 532 € 273,03 € 145.252
Jun 25, 2025
Kaye Daniel G
Director
grant 532 € 273,03 € 145.252
Jun 25, 2025
Hobert William W
Director
grant 879 € 273,03 € 239.993
Jun 25, 2025
Maloney Patrick W
Director
grant 532 € 273,03 € 145.252
Jun 25, 2025
Lockett Phyllis M
Director
grant 532 € 273,03 € 145.252
Jun 25, 2025
Seifu Rahael
Director
grant 532 € 273,03 € 145.252

Belangrijkste Punten

Revenue grew 8,59% annually over 5 years — modest growth
ROE of 14,65% — decent returns on equity
Net margin of 62,02% shows strong profitability
Debt/Equity of 0,13 — conservative balance sheet
Generating 4,19B in free cash flow
Cash machine — converts 103,69% of earnings into free cash flow

Groei

Revenue Growth (5Y)
8,59%
Revenue (1Y)6,37%
Earnings (1Y)14,71%
FCF Growth (3Y)11,43%

Kwaliteit

Return on Equity
14,65%
ROIC9,76%
Net Margin62,02%
Op. Margin64,86%

Veiligheid

Debt / Equity
0,13
Current Ratio92,97
Interest Coverage32,61

Waardering

P/E Ratio
27,25
P/B Ratio3,84
EV/EBITDA25,90
Dividend Yield0,04%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 6,37% Revenue Growth (3Y) 8,11%
Earnings Growth (1Y) 14,71% Earnings Growth (3Y) 11,96%
Revenue Growth (5Y) 8,59% Earnings Growth (5Y) 11,29%
Profitability
Revenue (TTM) 6,52B Net Income (TTM) 4,04B
ROE 14,65% ROA 2,04%
Gross Margin 86,09% Operating Margin 64,86%
Net Margin 62,02% Free Cash Flow (TTM) 4,19B
ROIC 9,76% FCF Growth (3Y) 11,43%
Safety
Debt / Equity 0,13 Current Ratio 92,97
Interest Coverage 32,61 Dividend Yield 0,04%
Valuation
P/E Ratio 27,25 P/B Ratio 3,84
P/S Ratio 16,90 PEG Ratio 1,58
EV/EBITDA 25,90 Dividend Yield 0,04%
Market Cap 110,21B Enterprise Value 109,55B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 6,52B 6,13B 5,58B 5,02B 4,69B
Net Income 4,04B 3,53B 3,23B 2,69B 2,64B
EPS (Diluted) 11,16 9,67 8,86 7,40 7,29
Gross Profit 5,61B 5,28B 4,75B 4,27B 3,85B
Operating Income 4,23B 3,93B 3,44B 3,02B 2,65B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 198,55B 137,45B 129,71B 174,18B 196,78B
Total Liabilities 169,82B 110,96B 102,97B 147,30B 169,38B
Shareholders' Equity 28,73B 26,49B 26,74B 26,88B 27,40B
Total Debt 3,76B 3,43B 3,43B 3,44B 3,45B
Cash & Equivalents 4,42B 2,89B 2,91B 2,72B 2,83B
Current Assets 5,19B 103,03B 94,89B 139,08B 161,76B
Current Liabilities 55,80M 102,31B 93,42B 137,69B 160,40B

Strategiescores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#869 of 1024
27

Recente Activiteit

Ingestapt Cash Flow Compounder
Mar 24, 2026